Tiffany Olson - Jul 1, 2024 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Frank Stokes, Attorney-in-fact
Stock symbol
CSTL
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 04:13 PM
Previous filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Options Exercise +830 +5.06% 17.2K Jul 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSTL Restricted Stock Units Award $0 +830 $0.00 830 Jul 1, 2024 Common Stock 830 Direct F1
transaction CSTL Restricted Stock Units Options Exercise $0 -830 -100% $0.00* 0 Jul 1, 2024 Common Stock 830 Direct F1
transaction CSTL Stock option (right to buy) Award $0 +3.38K $0.00 3.38K Jul 1, 2024 Common Stock 3.38K $71.22 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Discretionary grants to address an administrative oversight following the issuer's 2021 annual meeting of stockholders where the filing person did not receive automatic annual grants in accordance with the issuer's nonemployee director compensation policy. Since the restricted stock units are payment in respect of 2021 compensation, they are subject to immediate vesting. Each unit converts into a share of common stock on a one-for-one basis.